Dr. Kenneth Pennington, M.D

NPI: 1144200684
Total Payments
$1,167
2022 Payments
$113.34
Companies
17
Transactions
61
Medicare Patients
252
Medicare Billing
$34,841

Payment Breakdown by Category

Food & Beverage$1,080 (92.6%)
Education$86.91 (7.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,080 59 92.6%
Education $86.91 2 7.4%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme Corporation $210.58 9 $0 (2019)
Janssen Biotech, Inc. $173.75 8 $0 (2019)
AstraZeneca Pharmaceuticals LP $113.34 1 $0 (2022)
Celgene Corporation $113.06 6 $0 (2019)
E.R. Squibb & Sons, L.L.C. $93.95 7 $0 (2019)
Novartis Pharmaceuticals Corporation $77.67 5 $0 (2017)
Amgen Inc. $68.01 5 $0 (2018)
Genentech USA, Inc. $65.28 5 $0 (2019)
PFIZER INC. $52.59 4 $0 (2018)
Lilly USA, LLC $48.38 3 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2022 $113.34 1 AstraZeneca Pharmaceuticals LP ($113.34)
2021 $11.92 1 Gilead Sciences, Inc. ($11.92)
2019 $233.18 14 E.R. Squibb & Sons, L.L.C. ($46.74)
2018 $365.40 15 Janssen Biotech, Inc. ($118.49)
2017 $442.80 30 Novartis Pharmaceuticals Corporation ($77.67)

All Payment Transactions

61 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
04/20/2022 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $113.34 General
Category: Oncology
06/01/2021 Gilead Sciences, Inc. Education In-kind items and services $11.92 General
12/30/2019 Lilly USA, LLC CYRAMZA (Drug) Food and Beverage In-kind items and services $14.12 General
Category: Oncology
10/31/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $11.23 General
Category: ONCOLOGY
10/24/2019 Bayer HealthCare Pharmaceuticals Inc. Vitrakvi (Drug), Aliqopa Food and Beverage In-kind items and services $13.10 General
Category: Oncology
10/03/2019 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $20.55 General
Category: Oncology
09/12/2019 Celgene Corporation Abraxane (Drug) Food and Beverage In-kind items and services $17.44 General
Category: Oncology
08/22/2019 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $13.50 General
Category: Oncology
07/11/2019 Genentech USA, Inc. Alecensa (Biological), TECENTRIQ Food and Beverage In-kind items and services $12.47 General
Category: BioOncology
06/27/2019 Lilly USA, LLC CYRAMZA (Drug) Food and Beverage In-kind items and services $19.26 General
Category: Oncology
06/20/2019 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $12.69 General
Category: Oncology
05/30/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $13.53 General
Category: ONCOLOGY
05/23/2019 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $15.00 General
Category: ONCOLOGY
05/02/2019 Janssen Biotech, Inc. DARZALEX (Biological), Erleada Food and Beverage In-kind items and services $13.51 General
Category: Oncology
03/09/2019 Pharmacyclics LLC, An AbbVie Company Imbruvica (Drug) Food and Beverage In-kind items and services $44.12 General
Category: Oncology
01/10/2019 Janssen Biotech, Inc. Erleada (Drug), DARZALEX Food and Beverage In-kind items and services $12.66 General
Category: Oncology
11/12/2018 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $11.98 General
Category: Oncology
09/11/2018 Janssen Biotech, Inc. DARZALEX (Biological), Erleada Food and Beverage In-kind items and services $12.03 General
Category: Oncology
05/29/2018 E.R. Squibb & Sons, L.L.C. SPRYCEL (Drug) Food and Beverage Cash or cash equivalent $12.01 General
Category: Oncology
05/22/2018 Amgen Inc. Kyprolis (Biological), XGEVA Food and Beverage In-kind items and services $13.08 General
Category: Oncology
05/11/2018 Janssen Biotech, Inc. Erleada (Drug), ZYTIGA, DARZALEX Food and Beverage In-kind items and services $16.87 General
Category: Oncology
05/08/2018 Celgene Corporation Abraxane (Drug) Food and Beverage In-kind items and services $16.32 General
Category: Oncology
04/18/2018 Janssen Biotech, Inc. IMBRUVICA (Drug) Education In-kind items and services $74.99 General
Category: Oncology
04/17/2018 Janssen Biotech, Inc. DARZALEX (Drug) Food and Beverage In-kind items and services $14.60 General
Category: Oncology
04/10/2018 Genentech USA, Inc. TECENTRIQ (Biological) Food and Beverage In-kind items and services $11.54 General
Category: BioOncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 3 115 263 $38,075 $19,493
2020 4 137 283 $35,762 $15,348
Total Patients
252
Total Services
546
Medicare Billing
$34,841
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 63 170 $20,400 $10,552 51.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 38 79 $13,825 $7,451 53.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 14 14 $3,850 $1,490 38.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 71 211 $25,320 $11,164 44.1%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 26 26 $5,070 $1,732 34.2%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 17 20 $3,500 $1,636 46.7%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Office 2020 23 26 $1,872 $816.92 43.6%

About Dr. Kenneth Pennington, M.D

Dr. Kenneth Pennington, M.D is a Specialist healthcare provider based in Goshen, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144200684.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Pennington, M.D has received a total of $1,167 in payments from pharmaceutical and medical device companies, with $113.34 received in 2022. These payments were reported across 61 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,080).

As a Medicare-enrolled provider, Pennington has provided services to 252 Medicare beneficiaries, totaling 546 services with total Medicare billing of $34,841. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Medical Oncology
  • Location Goshen, IN
  • Active Since 01/19/2006
  • Last Updated 03/11/2019
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1144200684

Products in Payments

  • KEYTRUDA (Biological) $170.87
  • CALQUENCE (Drug) $113.34
  • IMBRUVICA (Drug) $74.99
  • OPDIVO (Biological) $69.17
  • Abraxane (Drug) $68.91
  • Imbruvica (Drug) $44.12
  • IBRANCE (Drug) $42.25
  • Kyprolis (Biological) $40.67
  • CYRAMZA (Drug) $33.38
  • AFINITOR (Drug) $31.35
  • Erleada (Drug) $29.53
  • ZYTIGA (Drug) $29.09
  • Neulasta (Biological) $27.34
  • TECENTRIQ (Biological) $25.70
  • DARZALEX (Biological) $25.54
  • JADENU (Drug) $24.88
  • SPRYCEL (Drug) $24.78
  • Revlimid (Drug) $22.12
  • Pomalyst (Drug) $22.03
  • TASIGNA (Drug) $21.44

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Goshen